Chronic Myeloid Leukemia

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Hematology
Cover of the book Chronic Myeloid Leukemia by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319331980
Publisher: Springer International Publishing Publication: August 17, 2016
Imprint: Springer Language: English
Author:
ISBN: 9783319331980
Publisher: Springer International Publishing
Publication: August 17, 2016
Imprint: Springer
Language: English

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the forthcoming impact of availability of generic imatinib. 

More books from Springer International Publishing

Cover of the book Enterprises, Localities, People, and Policy in the South China Sea by
Cover of the book Policy Implications of Virtual Work by
Cover of the book Inclusive Education and Disability in the Global South by
Cover of the book New Digital Technology in Education by
Cover of the book High Speed Rail and Access Transit Networks by
Cover of the book Research Trends in Mathematics Teacher Education by
Cover of the book SmartParticipation by
Cover of the book Endothelial Progenitor Cells by
Cover of the book Automated Electronic Filter Design by
Cover of the book Panic Disorder by
Cover of the book Urban Governance and Informal Settlements by
Cover of the book Energy Consumption and Autonomous Driving by
Cover of the book Asbestos and Mesothelioma by
Cover of the book High-Resolution Profiling of Protein-RNA Interactions by
Cover of the book Democracy and an Open-Economy World Order by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy